Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03514277 · ClinicalTrials.gov registry record · Phase 4
A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief
A Phase 4 study, sponsored by Virtua Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT03514277 is a Phase 4 study that was terminated before completion, run by Virtua Health. The registered enrollment target is 19 participants.
The verdict
NCT03514277, a Phase 4 study, was terminated before completion, sponsored by Virtua Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information about how patients feel when doctors manage their pain after lumbar spine surgery using a combination of EXPAREL® and bupivacaine injected into the lumbar spine at the end of surgery, compared to the patients that doctors use only EXPAREL® or bupivacaine to manage their pain. This information will help doctors determine which approach works best for patients who will receive surgery in their lumbar spine in the future.
Interventions
- DRUG Bupivacaine
- DRUG Exparel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-12-01 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03514277
The ClinicalTrials.gov registry entry for NCT03514277 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virtua Health, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03514277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03514277 about?
NCT03514277 is a clinical study titled "A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief". The purpose of this study is to collect information about how patients feel when doctors manage their pain after lumbar spine surgery using a combination of EXPAREL® and bupivacaine injected into the lumbar spine at the end of surgery, compared to the patients that doctors use only EXPAREL® or bupiv...
What is the current status of trial NCT03514277?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2016-12-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03514277?
The interventions under investigation include: Bupivacaine (DRUG), Exparel (DRUG).
Who is sponsoring clinical trial NCT03514277?
This trial is sponsored by Virtua Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.